Image from PronoKal’s Facebook page

Vevey, Switzerland-based Nestlé Health Science is acquiring European medical weight loss treatment company PronoKal Group.

Founded in 2004 and based in Barcelona, PronoKal Group provides a treatment method combining medical prescription, dietary products, nutritional coaching, physical training and applied genomics.

PronoKal Group is a portfolio company of Abac Capital, a Barcelona-based private equity fund that invests in Spain-based SMEs, with institutional investors from Europe, the US and the Asia-Pacific region.

Nestlé Health Science, a subsidiary of Nestlé, operates in the field of nutritional science and has a consumer health portfolio of medical nutrition, consumer and vitamins, minerals, and supplements brands covering facets of health, including prevention, maintenance and treatment.

William Blair was exclusive financial advisor to PronoKal Group in connection with the pending sale. The transaction has been signed and is expected to close by the end of next month.

Date published: 10 February 2022

Continue reading

Subscribe to get unlimited digital access.


Already a subscriber? Login